Barclays’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $826K | Sell |
|
|||||
|
2025
Q2 | $1.03M | Buy |
|
|||||
|
2025
Q1 | $962K | Sell |
|
|||||
|
2024
Q4 | $1.49M | Buy |
|
|||||
|
2024
Q3 | $1.55M | Buy |
|
|||||
|
2024
Q2 | $436K | Sell |
|
|||||
|
2024
Q1 | $867K | Sell |
|
|||||
|
2023
Q4 | $1.43M | Buy |
|
|||||
|
2023
Q3 | $664K | Buy |
|
|||||
|
2023
Q2 | $574K | Buy |
|
|||||
|
2023
Q1 | $37K | Sell |
|
|||||
|
2022
Q4 | $226K | Sell |
|
|||||
|
2022
Q3 | $185K | Sell |
|
|||||
|
2022
Q2 | $315K | Sell |
|
|||||
|
2022
Q1 | $1.06M | Buy |
|
|||||
|
2021
Q4 | $95K | Sell |
|
|||||
|
2021
Q3 | $548K | Sell |
|
|||||
|
2021
Q2 | $1.02M | Sell |
|
|||||
|
2021
Q1 | $878K | Sell |
|
|||||
|
2020
Q4 | $946K | Sell |
|
|||||
|
2020
Q3 | $577K | Buy |
|
|||||
|
2020
Q2 | $425K | Sell |
|
|||||
|
2020
Q1 | $756K | Sell |
|
|||||
|
2019
Q4 | $12.2M | Buy |
|
|||||
|
2019
Q3 | $13.7M | Buy |
|
|||||
|
2019
Q2 | $14.9M | Buy |
|
|||||
|
2019
Q1 | $18.2M | Buy |
|
|||||
|
2018
Q4 | $15.7M | Sell |
|
|||||
|
2018
Q3 | $30.7M | Sell |
|
|||||
|
2018
Q2 | $36M | Buy |
|
|||||
|
2018
Q1 | $1.43M | Sell |
|
|||||
|
2017
Q4 | $1.72M | Sell |
|
|||||
|
2017
Q3 | $1.92M | Sell |
|
|||||
|
2017
Q2 | $2.14M | Sell |
|
|||||
|
2017
Q1 | $2.5M | Sell |
|
|||||
|
2016
Q4 | $2.74M | Sell |
|
|||||
|
2016
Q3 | $3.72M | Buy |
|
|||||
|
2016
Q2 | $3.43M | Sell |
|
|||||
|
2016
Q1 | $3.44M | Sell |
|
|||||
|
2015
Q4 | $4.19M | Sell |
|
|||||
|
2015
Q3 | $4.44M | Sell |
|
|||||
|
2015
Q2 | $6.63M | Sell |
|
|||||
|
2015
Q1 | $16.3M | Buy |
|
|||||
|
2014
Q4 | $11.3M | Buy |
|
|||||
|
2014
Q3 | $8.59M | Buy |
|
|||||
|
2014
Q2 | $8.25M | Sell |
|
|||||
|
2014
Q1 | $10.3M | Sell |
|
|||||
|
2013
Q4 | $10.1M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $8.13M | Buy |
|